Market Currents
Generex (GNBT +28%) is up strongly after the FDA said earlier this morning it will allow...
-
Thursday, September 10, 2009, 11:29 AM ETGenerex (GNBT +28%) is up strongly after the FDA said earlier this morning it will allow patients with serious or life-threatening diabetes to use its yet-unapproved orally-administered insulin product Oral-lyn. (PR)
Other date
Latest Articles
